150
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Relationship of Red Cell Index with the Severity of Chronic Obstructive Pulmonary Disease

ORCID Icon, , , , , , , , , , & ORCID Icon show all
Pages 825-834 | Published online: 26 Mar 2021

References

  • Lopez-Campos JL, Tan W, Soriano JB. Global burden of COPD. Respirology. 2016;21(1):14–23. doi:10.1111/resp.12660
  • Rabe KF, Watz H. Chronic obstructive pulmonary disease. The Lancet. 2017;389(10082):1931–1940. doi:10.1016/s0140-6736(17)31222-9
  • Eisner M, Blanc P, Sidney S, et al. Body composition and functional limitation in COPD. Respir Res. 2007;8:7. doi:10.1186/1465-9921-8-7
  • Andelid K, Bake B, Rak S, Linden A, Rosengren A, Ekberg-Jansson A. Myeloperoxidase as a marker of increasing systemic inflammation in smokers without severe airway symptoms. Respir Med. 2007;101(5):888–895. doi:10.1016/j.rmed.2006.09.023
  • Houghton AM, Rzymkiewicz DM, Ji H, et al. Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth. Nat Med. 2010;16(2):219–223. doi:10.1038/nm.2084
  • El-Gazzar A, Kamel M, Elbahnasy O, El-Naggar MJ. Prognostic value of platelet and neutrophil to lymphocyte ratio in COPD patients. 2020;14(1):111–116. doi:10.1080/17476348.2019.1675517
  • Nunez A, Marras V, Harlander M, et al. Association between routine blood biomarkers and clinical phenotypes and exacerbations in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2020;15:681–690. doi:10.2147/COPD.S240720
  • Skoczynski S, Krzyzak D, Studnicka A, et al. Chronic obstructive pulmonary disease and platelet count. Adv Exp Med Biol. 2019;1160:19–23. doi:10.1007/5584_2019_379
  • Makhlouf H, Sadek S, Nafady AJT. Platelet function in diabetic and nondiabetic patients with chronic obstructive pulmonary disease: a case control study. Clin Respir J. 2018;12(1):48–56. doi:10.1111/crj.12477
  • Guo J, Zheng C, Xiao Q, et al. Impact of anaemia on lung function and exercise capacity in patients with stable severe chronic obstructive pulmonary disease. BMJ Open. 2015;5(10):e008295. doi:10.1136/bmjopen-2015-008295
  • Rasmussen L, Christensen S, Lenler-Petersen P, Johnsen SP. Anemia and 90-day mortality in COPD patients requiring invasive mechanical ventilation. Clin Epidemiol. 2010;3:1–5. doi:10.2147/CLEP.S12885
  • Gadre SK, Jhand AS, Abuqayyas S, Wang X, Guzman J, Duggal A. Effect of anemia on mortality in mechanically ventilated patients with Chronic Obstructive Pulmonary Disease. J Intensive Care Med. 2020;35(3):251–256. doi:10.1177/0885066617739561
  • Guang Y, Jie Z, Feng D, Hui L. Surrogate scale for evaluating respiratory function based on complete blood count parameters. J Clin Lab Anal. 2018;32(5):e22385. doi:10.1002/jcla.22385
  • Vogelmeier C, Criner G, Martinez F, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD Executive Summary. 2017;195(5):557–582. doi:10.1164/rccm.201701-0218PP
  • Guang Y, Jie Z, Feng D, Hui LJ. Surrogate scale for evaluating respiratory function based on complete blood count parameters. J Clin Lab Anal. 2018;32(5):e22385. doi:10.1002/jcla.22385
  • Şahin F, Koşar A, Aslan A, Yiğitbaş B, Uslu BJJ. Serum biomarkers in patients with stable and acute exacerbation of chronic obstructive pulmonary disease: a comparative study. J Med Biochem. 2019;38(4):503–511. doi:10.2478/jomb-2018-0050
  • Skoczyński S, Krzyżak D, Studnicka A, et al. Chronic obstructive pulmonary disease and platelet count. Advan Exp Med Biol. 2019;1160:19–23. doi:10.1007/5584_2019_379
  • García-Rivero J, Esquinas C, Barrecheguren M, et al. Risk factors of poor outcomes after admission for a COPD exacerbation: multivariate logistic predictive models. COPD. 2017;14(2):164–169. doi:10.1080/15412555.2016.1260538
  • JAjor and medicine, cc. ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med. 2002;166(4):518–624. doi:10.1164/rccm.166.4.518.
  • Vaz Fragoso CA, Concato J, McAvay G, et al. The ratio of FEV1 to FVC as a basis for establishing chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;181(5):446–451. doi:10.1164/rccm.200909-1366OC
  • Agarwala P, Salzman SJC. Six-minute walk test: clinical role, technique, coding, and reimbursement. Chest. 2020;157(3):603–611. doi:10.1016/j.chest.2019.10.014
  • Chu J, Chen X, Shen S, et al. A poor performance in comprehensive geriatric assessment is associated with increased fall risk in elders with hypertension: a cross-sectional study. J Geriatric Cardiol. 2015;12(2):113–118. doi:10.11909/j.issn.1671-5411.2015.02.006
  • Celli B, Cote C, Marin J, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005–1012. doi:10.1056/NEJMoa021322
  • Puhan M, Garcia-Aymerich J, Frey M, et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet (London, England). 2009;374(9691):704–711. doi:10.1016/s0140-6736(09)61301-5
  • Jones R, Donaldson G, Chavannes N, et al. Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE Index. Am J Respir Crit Care Med. 2009;180(12):1189–1195. doi:10.1164/rccm.200902-0271OC
  • Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–365. doi:10.1164/rccm.201204-0596PP
  • Acanfora D, Scicchitano P, Carone M, et al. Relative lymphocyte count as an indicator of 3-year mortality in elderly people with severe COPD. BMC Pulm Med. 2018;18(1):116. doi:10.1186/s12890-018-0685-6
  • Şahin F, Koşar AF, Aslan AF, Yiğitbaş B, Uslu B. Serum biomarkers in patients with stable and acute exacerbation of chronic obstructive pulmonary disease: a comparative study. J Med Biochem. 2019;38(4):503–511. doi:10.2478/jomb-2018-0050
  • Collins PF, Elia M, Kurukulaaratchy RJ, Stratton RJ. The influence of deprivation on malnutrition risk in outpatients with chronic obstructive pulmonary disease (COPD). Clin Nutr. 2018;37(1):144–148. doi:10.1016/j.clnu.2016.11.005
  • Casanova C, Marin J, Martinez-Gonzalez C, et al. Differential effect of modified medical research council dyspnea, COPD assessment test, and clinical COPD questionnaire for symptoms evaluation within the new GOLD Staging and Mortality in COPD. Chest. 2015;148(1):159–168. doi:10.1378/chest.14-2449
  • Samaja M, Crespi T, Guazzi M, Vandegriff KD. Oxygen transport in blood at high altitude: role of the hemoglobin-oxygen affinity and impact of the phenomena related to hemoglobin allosterism and red cell function. Eur J Appl Physiol. 2003;90(3–4):351–359. doi:10.1007/s00421-003-0954-8
  • Gong H, Linn WS, Terrell SL, et al. Exposures of elderly volunteers with and without chronic obstructive pulmonary disease (COPD) to concentrated ambient fine particulate pollution. Inhal Toxicol. 2004;16(11–12):731–744. doi:10.1080/08958370490499906
  • Santos MC, Oliveira AL, Viegas-Crespo AM, et al. Systemic markers of the redox balance in chronic obstructive pulmonary disease. Biomarkers. 2004;9(6):461–469. doi:10.1080/13547500400024768
  • Park SC, Kim YS, Kang YA, et al. Hemoglobin and mortality in patients with COPD: a nationwide population-based cohort study. Int J Chron Obstruct Pulmon Dis. 2018;13:1599–1605. doi:10.2147/COPD.S159249
  • Ergan B, Ergun R. Impact of anemia on short-term survival in severe COPD exacerbations: a cohort study. Int J Chron Obstruct Pulmon Dis. 2016;11:1775–1783. doi:10.2147/COPD.S111758
  • Maclay JD, McAllister DA, Johnston S, et al. Increased platelet activation in patients with stable and acute exacerbation of COPD. Thorax. 2011;66(9):769–774. doi:10.1136/thx.2010.157529
  • Gunay E, Sarinc Ulasli S, Akar O, et al. Neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: a retrospective study. Inflammation. 2014;37(2):374–380. doi:10.1007/s10753-013-9749-1
  • Paliogiannis P, Fois AG, Sotgia S, et al. The neutrophil-to-lymphocyte ratio as a marker of chronic obstructive pulmonary disease and its exacerbations: a systematic review and meta-analysis. Eur J Clin Invest. 2018;48(8):e12984. doi:10.1111/eci.12984
  • Gao X, Coull B, Lin X, et al. Association of neutrophil to lymphocyte ratio with pulmonary function in a 30-year longitudinal study of US veterans. 2020;3(7):e2010350. doi:10.1001/jamanetworkopen.2020.10350
  • Yao C, Liu X, Tang Z. Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD. Int J Chron Obstruct Pulmon Dis. 2017;12:2285–2290. doi:10.2147/COPD.S141760
  • Günay E, Sarınç Ulaşlı S, Akar O, et al. Neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: a retrospective study. Inflammation. 2014;37(2):374–380. doi:10.1007/s10753-013-9749-1
  • Grabicki M, Kuźnar-Kamińska B, Rubinsztajn R, et al. COPD course and comorbidities: are there gender differences? Advan Exp Med Biol. 2019;1113:43–51. doi:10.1007/5584_2018_160
  • Ntritsos G, Franek J, Belbasis L, et al. Gender-specific estimates of COPD prevalence: a systematic review and meta-analysis. Int J Chronic Obstructive Pulmonary Dis. 2018;13:1507–1514. doi:10.2147/copd.S146390